Media Coverage

Quest Diagnostics said Tuesday it is now sequencing 2,000 tests a week, doubling the amount of genomic sequencing it started performing last month. The company said it is sequencing the tests for the US Centers for Disease Control and Prevention.

Steve Rusckowski, Quest Diagnostics CEO, joins ‘Closing Bell’ to discuss coronavirus testing, covid variants, and his outlook on the pandemic as coronavirus cases decrease in the U.S.

Quest Diagnostics said Thursday that continued high demand for Covid-19 testing helped drive record revenue and earnings for the company in the fourth quarter and throughout 2020.

In this latest episode of the "MHE Talks: Improving Patient Access" series, Senior Editor of MHE, Peter Wehrwein, speaks with Harvey Kaufman, M.D., FCAP, MBA, senior medical director of medical informatics at Quest Diagnostics. The two discussed a recent Quest Diagnostics Health Trends report examining healthcare disparities.

A new Quest Diagnostics survey found Black and Latino Americans are nearly two times as likely as white Americans to say their access to COVID-19 vaccines - when available - would be worse than other racial or ethnic groups.